{"issuance_frequency":"","notes_translated":{"fr":"Le présent document offre de l'information à l'intention de l'industrie sur la manière dont la Direction générale des produits de santé et des aliments de Santé Canada interprète et applique le Règlement modifiant le Règlement sur les aliments et drogues (étiquetage, emballage et marques nominatives des drogues pour usage humain) de 2014 pour les produits sur ordonnance et ceux qui sont administrés ou délivrés par un professionnel de la santé. Veuillez noter que cela inclut les produits pharmaceutiques sur ordonnance, les produits biologiques (annexe D) et les produits radiopharmaceutiques (annexe C).","en":"This document provides information for industry on how Health Canada's Health Products and Food Branch interprets and applies the 2014 Regulations Amending the Food and Drug Regulations (Labelling, Packaging and Brand Names of Drugs for Human Use) for prescription products and those administered or obtained through a health professional. Please note that this includes prescription pharmaceutical drugs, biologic drugs (Schedule D), and radiopharmaceuticals (Schedule C). "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"4e0bec14-a324-412f-b567-fa8e0813ca0f","metadata_created":"2021-07-07T16:51:44.501661","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-07T16:51:44.501667","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["questions et réponses","règlements sur l'étiquetage en langage clair","médicaments sur ordonnance","étiquetage","emballage et noms de marque des médicaments","médicaments à usage humain","médicaments pharmaceutiques sur ordonnance","médicaments biologiques","annexe-D","produits radiopharmaceutiques","annexe-C"],"en":["questions and answers","plain language labelling regulations","prescription drugs","labelling","packaging and brand names of drugs","drugs for human use","prescription pharmaceutical drugs","biologic drugs","schedule-D","radiopharmaceuticals","schedule-C"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Questions-réponses : Le règlement sur l’étiquetage en langage clair pour les médicaments sur ordonnance - document","en":"Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"4e0bec14-a324-412f-b567-fa8e0813ca0f","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2fc6d5aa-1432-4ddf-9fd7-9deb5c061171","related_relationship":"","name_translated":{"fr":"Questions-réponses : Le règlement sur l’étiquetage en langage clair pour les médicaments sur ordonnance - document","en":"Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document","language":["en"],"created":"2021-07-07T16:51:44.593151","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/questions-answers-plain-language-labelling-2019/document.html#s1.1","last_modified":null,"position":0,"revision_id":"919193eb-8820-4750-a423-09f18763197f","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"4e0bec14-a324-412f-b567-fa8e0813ca0f","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"76217ffc-073c-4960-884c-40d2d40ee2a5","related_relationship":"","name_translated":{"fr":"Questions-réponses : Le règlement sur l’étiquetage en langage clair pour les médicaments sur ordonnance - document","en":"Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document","language":["fr"],"created":"2021-07-07T16:51:44.593157","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/questions-reponses-reglement-etiquetage-langage-clair-2019/document.html#s1","last_modified":null,"position":1,"revision_id":"919193eb-8820-4750-a423-09f18763197f","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-05-14 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"4e0bec14-a324-412f-b567-fa8e0813ca0f","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This document provides information for industry on how Health Canada's Health Products and Food Branch interprets and applies the 2014 Regulations Amending the Food and Drug Regulations (Labelling, Packaging and Brand Names of Drugs for Human Use) for prescription products and those administered or obtained through a health professional. Please note that this includes prescription pharmaceutical drugs, biologic drugs (Schedule D), and radiopharmaceuticals (Schedule C). ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document","revision_id":"919193eb-8820-4750-a423-09f18763197f"}